Collegium Pharmaceutical, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 599
EBIT TTM (mln): 199
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 2 28 280 297 310 277 464 567 631
Przychód Δ r/r 0.0% 0.0% 0.0% inf% 1564.3% 884.7% 5.8% 4.5% -10.7% 67.6% 22.2% 11.4%
Marża brutto 0.0% 0.0% 0.0% 87.6% 90.9% 40.9% 34.7% 58.0% 54.4% 45.2% 57.5% 59.8%
EBIT (mln) -16 -18 -27 -94 -75 -21 -24 -5 -47 -105 167 170
EBIT Δ r/r 0.0% 10.1% 52.3% 249.7% -19.8% -72.6% 14.8% -78.6% 818.2% 123.9% -259.7% 1.8%
EBIT (%) 0.0% 0.0% 0.0% -5498.7% -264.9% -7.4% -8.0% -1.6% -16.9% -22.5% 29.5% 26.9%
Koszty finansowe (mln) 0 0 0 0 1 20 1 29 21 63 83 74
EBITDA (mln) -16 -17 -27 -94 -75 -19 -22 56 22 34 332 170
EBITDA(%) 0.0% 0.0% 0.0% -5498.7% -262.9% -6.8% -7.4% 18.2% 8.0% 7.4% 58.5% 26.9%
Podatek (mln) 0 0 -0 0 -1 -111 -15 1 -75 -4 28 29
Zysk Netto (mln) -16 -18 -27 -94 -75 -39 -8 27 72 -25 48 69
Zysk netto Δ r/r 0.0% 10.6% 52.1% 245.5% -20.5% -47.7% -79.2% -428.3% 167.3% -135.0% -292.6% 43.7%
Zysk netto (%) 0.0% 0.0% 0.0% -5504.1% -262.9% -14.0% -2.7% 8.6% 25.8% -5.4% 8.5% 11.0%
EPS -2.17 -2.4 -2.01 -3.88 -2.47 -1.19 -0.24 0.78 2.05 -0.74 1.43 2.14
EPS (rozwodnione) -2.17 -2.4 -2.01 -3.88 -2.47 -1.19 -0.24 0.76 1.86 -0.74 1.29 1.71
Ilośc akcji (mln) 7 7 14 24 30 33 33 34 35 34 34 32
Ważona ilośc akcji (mln) 7 7 14 24 30 33 33 35 41 34 42 40
Waluta USD USD USD USD USD USD USD USD USD USD USD USD